Is stem cell therapy for Chronic Kidney Disease FDA-approved?
No generic stem-cell or exosome product is FDA-approved to treat CKD. A research designation, autologous source or renal-clinic setting is not product approval for this indication.
How stem cells are studied for Chronic Kidney Disease
Chronic kidney disease (CKD) is persistent kidney damage or reduced filtration caused by diabetes, hypertension, immune, genetic, obstructive and other disorders. Cell and exosome research explores inflammatory, vascular and repair mechanisms, but a laboratory signal does not establish restored nephron number, delayed kidney failure or avoidance of dialysis or transplantation.
Am I a candidate? → · Chronic Kidney Disease: full overview → · Chronic Kidney Disease cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Chronic Kidney Disease: cell-therapy evidence and registered trials
- How much does stem cell therapy for Chronic Kidney Disease cost? (2026)
- Chronic Kidney Disease stem cell therapy — your questions answered (2026)
- Chronic Kidney Disease: cell-therapy evidence by therapy class
- MSC vs HSCT for Chronic Kidney Disease: what the registries show